Selected article for: "acute respiratory syndrome and lymphocyte response"

Author: Ni, Yanghong; Alu, Aqu; Lei, Hong; Wang, Yang; Wu, Min; Wei, Xiawei
Title: Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
  • Cord-id: 68fb87wk
  • Document date: 2021_1_20
  • ID: 68fb87wk
    Snippet: Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). COVID-19 can spread to the entire body and cause multiple organ failure. It is a daunting challenge to control the fast growing worldwide pandemic because effective prevention and treatment strategies are unavailable currently. Generally, the immune response of the human body triggered by viral infection is essential for the elimination of the virus. However
    Document: Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). COVID-19 can spread to the entire body and cause multiple organ failure. It is a daunting challenge to control the fast growing worldwide pandemic because effective prevention and treatment strategies are unavailable currently. Generally, the immune response of the human body triggered by viral infection is essential for the elimination of the virus. However, severe COVID-19 patients may manifest dysregulated immune responses, such as lymphopenia, lymphocyte exhaustion, exacerbated antibody response, cytokine release syndrome (CRS), etc. Understanding of these immunological characteristics may help identify better approaches for diagnosis, prognosis and treatment of COVID-19 patients. As specific anti-viral agents are notoriously difficult to develop, strategies for modulating the immune responses by either developing novel vaccines or using immunotherapy hold great promise to improve the management of SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • absolute reduction and acute lung injury: 1
    • acceptable safety and acute ards respiratory distress syndrome: 1
    • accurate diagnosis and acid detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate diagnosis and acid testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • accurate diagnosis and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • accurate diagnosis and acute lung injury: 1, 2
    • acid detection and activator signal transducer: 1, 2
    • acid testing and acute lung injury: 1, 2
    • acid vaccine and acquire immunity: 1
    • activate protein and acute ards respiratory distress syndrome: 1
    • activate protein and acute lung injury: 1
    • activator signal transducer and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • activator signal transducer and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11